Stereotactic brainstem biopsy in a patient with coagulopathy of unclear etiology: case report

Parenchymal hemorrhage is one of the most feared risks of stereotactic brain biopsies potentially resulting in neurological deficits or even a fatal outcome. Patients with disorders of the coagulation system are at particular risk, so identifying these is one of the main tasks prior to surgery. Some...

Full description

Saved in:
Bibliographic Details
Main Authors: Beynon, Christopher (Author) , Wick, Wolfgang (Author) , Unterberg, Andreas (Author) , Kiening, Karl (Author)
Format: Article (Journal)
Language:English
Published: 25.Januar 2012
In: Minimally invasive neurosurgery
Year: 2011, Volume: 54, Issue: 05/06, Pages: 268-270
ISSN:1439-2291
DOI:10.1055/s-0031-1297989
Online Access:Verlag, Volltext: http://dx.doi.org/10.1055/s-0031-1297989
Verlag, Volltext: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0031-1297989
Get full text
Author Notes:C. Beynon, T. Hoffmann, W. Wick, A. W. Unterberg, K. L. Kiening
Description
Summary:Parenchymal hemorrhage is one of the most feared risks of stereotactic brain biopsies potentially resulting in neurological deficits or even a fatal outcome. Patients with disorders of the coagulation system are at particular risk, so identifying these is one of the main tasks prior to surgery. Some patients may have a bleeding tendency despite normal laboratory values of the hemostatic system.</p> <p>We report the case of a patient with coagulopathy of unclear etiology undergoing a stereotactic brainstem biopsy.</p> <p>A medication scheme with tranexamic acid and desmopressin effectively decreased the patient’s bleeding time in vivo and the procedure was carried out without complications.</p>
Item Description:Publikationsdatum: 25.Januar 2012 (online)
Gesehen am 15.06.2018
Physical Description:Online Resource
ISSN:1439-2291
DOI:10.1055/s-0031-1297989